128 related articles for article (PubMed ID: 15003957)
1. Association between initial disease presentation, lung disease outcomes, and survival in patients with cystic fibrosis.
Lai HJ; Cheng Y; Cho H; Kosorok MR; Farrell PM
Am J Epidemiol; 2004 Mar; 159(6):537-46. PubMed ID: 15003957
[TBL] [Abstract][Full Text] [Related]
2. The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: evidence from the United States Cystic Fibrosis Foundation registry data.
Lai HJ; Cheng Y; Farrell PM
J Pediatr; 2005 Sep; 147(3 Suppl):S57-63. PubMed ID: 16202784
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal pulmonary status of cystic fibrosis children with meconium ileus.
Li Z; Lai HJ; Kosorok MR; Laxova A; Rock MJ; Splaingard ML; Farrell PM
Pediatr Pulmonol; 2004 Oct; 38(4):277-84. PubMed ID: 15334503
[TBL] [Abstract][Full Text] [Related]
4. Delayed diagnosis of females with respiratory presentation of cystic fibrosis did not segregate with poorer clinical outcome.
McCormick J; Sims EJ; Mehta A
J Clin Epidemiol; 2006 Mar; 59(3):315-22. PubMed ID: 16488363
[TBL] [Abstract][Full Text] [Related]
5. Reduced survival in adult cystic fibrosis despite attenuated lung function decline.
Keating C; Poor AD; Liu X; Chiuzan C; Backenroth D; Zhang Y; DiMango E
J Cyst Fibros; 2017 Jan; 16(1):78-84. PubMed ID: 27522311
[TBL] [Abstract][Full Text] [Related]
6. Onset of persistent pseudomonas aeruginosa infection in children with cystic fibrosis with interval censored data.
Wang W; Chen MH; Chiou SH; Lai HC; Wang X; Yan J; Zhang Z
BMC Med Res Methodol; 2016 Sep; 16(1):122. PubMed ID: 27639560
[TBL] [Abstract][Full Text] [Related]
7. Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa.
Baussano I; Tardivo I; Bellezza-Fontana R; Forneris MP; Lezo A; Anfossi L; Castello M; Aleksandar V; Bignamini E
Pediatrics; 2006 Sep; 118(3):888-95. PubMed ID: 16950978
[TBL] [Abstract][Full Text] [Related]
8. Complications associated with symptomatic diagnosis in infants with cystic fibrosis.
Accurso FJ; Sontag MK; Wagener JS
J Pediatr; 2005 Sep; 147(3 Suppl):S37-41. PubMed ID: 16202780
[TBL] [Abstract][Full Text] [Related]
9. Familial concordance of phenotype and microbial variation among siblings with CF.
Picard E; Aviram M; Yahav Y; Rivlin J; Blau H; Bentur L; Avital A; Villa Y; Schwartz S; Kerem B; Kerem E
Pediatr Pulmonol; 2004 Oct; 38(4):292-7. PubMed ID: 15334505
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort.
Rosenfeld M; Emerson J; McNamara S; Thompson V; Ramsey BW; Morgan W; Gibson RL;
J Cyst Fibros; 2012 Sep; 11(5):446-53. PubMed ID: 22554417
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.
Sims EJ; Clark A; McCormick J; Mehta G; Connett G; Mehta A;
Pediatrics; 2007 Jan; 119(1):19-28. PubMed ID: 17200267
[TBL] [Abstract][Full Text] [Related]
12. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of birth order and age at diagnosis in cystic fibrosis: a sibling cohort study.
Slieker MG; van den Berg JM; Kouwenberg J; van Berkhout FT; Heijerman HG; van der Ent CK
Pediatr Pulmonol; 2010 Jun; 45(6):601-7. PubMed ID: 20503286
[TBL] [Abstract][Full Text] [Related]
14. Improved survival in cystic fibrosis patients diagnosed by newborn screening compared to a historical cohort from the same centre.
Dijk FN; McKay K; Barzi F; Gaskin KJ; Fitzgerald DA
Arch Dis Child; 2011 Dec; 96(12):1118-23. PubMed ID: 21994242
[TBL] [Abstract][Full Text] [Related]
15. Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients.
Mérelle ME; Schouten JP; Gerritsen J; Dankert-Roelse JE
Eur Respir J; 2001 Aug; 18(2):306-15. PubMed ID: 11529289
[TBL] [Abstract][Full Text] [Related]
16. Early pulmonary manifestation of cystic fibrosis in children with the DeltaF508/R117H-7T genotype.
O'Sullivan BP; Zwerdling RG; Dorkin HL; Comeau AM; Parad R
Pediatrics; 2006 Sep; 118(3):1260-5. PubMed ID: 16951024
[TBL] [Abstract][Full Text] [Related]
17. The decline and fall of pulmonary function in cystic fibrosis: new models, new lessons.
Davis PB
J Pediatr; 1997 Dec; 131(6):789-90. PubMed ID: 9427876
[No Abstract] [Full Text] [Related]
18. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study.
McKone EF; Emerson SS; Edwards KL; Aitken ML
Lancet; 2003 May; 361(9370):1671-6. PubMed ID: 12767731
[TBL] [Abstract][Full Text] [Related]
19. Improved pulmonary and growth outcomes in cystic fibrosis by newborn screening.
Collins MS; Abbott MA; Wakefield DB; Lapin CD; Drapeau G; Hopfer SM; Greenstein RM; Cloutier MM
Pediatr Pulmonol; 2008 Jul; 43(7):648-55. PubMed ID: 18500732
[TBL] [Abstract][Full Text] [Related]
20. Association of meteorological and geographical factors and risk of initial Pseudomonas aeruginosa acquisition in young children with cystic fibrosis.
Psoter KJ; DE Roos AJ; Wakefield J; Mayer JD; Bryan M; Rosenfeld M
Epidemiol Infect; 2016 Apr; 144(5):1075-83. PubMed ID: 26449886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
